Program

 

Tuesday, October 21, 2014

8:00 a.m. – 8:45 a.m. Registration & Networking Breakfast Buffet
8:45 a.m. – 9:00 a.m. Welcome

Debbie Hart, President and CEO, BioNJ
Francois Nader, M.D., President, CEO and Director, NPS Pharmaceuticals

9:00 a.m. – 9:45 a.m. Keynote

Geno Germano, Group President, Global Innovative Pharma Business, Pfizer Inc.

9:45 a.m. – 10:00 a.m. Presenting Company

Adam Grossman, President and CEO, ADMA Biologics, Inc.

10:00 a.m. – 10:45 a.m. Diving Deeper Into Outsourcing

Michael Griffith, Executive Vice President, inVentiv
Nancy Lurker, CEO, PDI, Inc.
Glen de Vries, President, Medidata Solutions

10:45 a.m. – 11:00 a.m. Break
11:00 a.m. – 11:45 a.m. Charting the Right Path; Finding the Good Footholds

Chris Garabedian, President and CEO, Sarepta Therapeutics
Francois Nader, M.D., President, CEO and Director, NPS Pharmaceuticals
Meg Tirrell, Reporter, CNBC

11:45 a.m. – 12:30 p.m. Finding Fertile Ground in the Financial Markets

Al Altomari, President, CEO and Director, Agile Therapeutics, Inc.
Kevin Davies, Managing Director, Co-Head of Healthcare Investment Banking, RBC Capital Markets
Michael Gaito, Managing Director, JP Morgan Healthcare Investment Banking
Tony Gibney, Managing Director, Leerink Partners LLC
Michael Margolis, Managing Director Healthcare Investment Banking, ROTH Capital Partners, LLC
Steven Cohen, Partner, Morgan Lewis

12:30 p.m. – 1:15 p.m. Creating a Patient Focused Culture of Excellence

Mark J. Alles, President and Chief Operating Officer, Celgene Corporation
Julie Kampf, CEO and President, JBK Associates International, Inc.

1:15 p.m. – 2:30 p.m. Luncheon & Keynote

Christi Shaw, US Country Head, President, Novartis Corporation and President, Novartis Pharmaceuticals Corporation

2:30 p.m. – 3:30 p.m. Closing Remarks & Dessert Networking Reception

By Invitation Only: BioNJ Board of Trustees, Speakers, Executive Suite Sponsors and Committee of Volunteers

Monday, October 20, 2014

6:00 p.m. – 7:00 p.m. Networking Reception
7:00 p.m. – 9:00 p.m. Welcome

Francois Nader, M.D., President, CEO and Director, NPS Pharmaceuticals

Fireside Chat

Frank Hatheway, Ph.D., Chief Economist, NASDAQ OMX Group Inc.
Karen Young, US Leader of Pharmaceutical and Life Sciences Assurance Practice, PricewaterhouseCoopers LLP